Auro Laboratories CFO resigns effective May 28, 2026
Auro Laboratories Limited disclosed the resignation of its CFO, Mr. Kuntal Pancholi, effective May 28, 2026, due to personal reasons. The company confirmed there are no other material reasons for the resignation and that he ceases to be a Key Managerial Personnel under the Companies Act, 2013.
*this image is generated using AI for illustrative purposes only.
Auro Laboratories Limited announced that Mr. Kuntal Pancholi has resigned from the position of Chief Financial Officer (CFO) and Key Managerial Personnel effective immediately. The resignation, effective from the close of business hours on May 28, 2026, was attributed to personal reasons with no other material cause cited. This change impacts the company's senior management structure as per the provisions of Section 203 of the Companies Act, 2013.
The company confirmed that Mr. Kuntal Pancholi ceased to be a Key Managerial Personnel from May 28, 2026. In a disclosure to the stock exchanges, the company stated that there is no other material reason for the resignation beyond those mentioned in the resignation letter. The resignation was accepted by the Board of Directors of Auro Laboratories Limited.
Regulatory Disclosure
The filing was made to BSE Limited under Regulation 30 of the SEBI (LODR) Regulations, 2015. The disclosure references SEBI Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The company provided the required details in Annexure A, confirming that the resignation letter is attached and there are no other material relationships to disclose.
Resignation Details
| Particulars | Details |
|---|---|
| Name | Mr. Kuntal Pancholi |
| Designation | Chief Financial Officer & Key Managerial Personnel |
| Reason for Resignation | Personal reasons |
| Effective Date | May 28, 2026 |
The resignation letter submitted by Mr. Kuntal Pancholi explicitly stated that there are no other material reasons for his departure. He expressed gratitude for the trust and support received during his tenure and wished the company continued success. The communication was signed by Siddhartha Deorah, Whole Time Director of Auro Laboratories Limited.
Historical Stock Returns for Auro Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.18% | +3.71% | +11.40% | +15.55% | +12.58% | +151.18% |
Who will Auro Laboratories appoint as the interim or permanent CFO to fill the immediate vacancy?
How might this sudden leadership change impact the company's upcoming financial reporting and strategic planning?
Will the resignation trigger any revisions to Auro Laboratories' financial guidance for the current fiscal year?
16
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
